Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 576-600 of 794 matching filings.

Per page
25
Current page
24
4

FORM 4

Filing date
04 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Sep 2017
Reporting date
26 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
22 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
22 Sep 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Sep 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
07 Aug 2017
Reporting date
07 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
17 Jul 2017
Reporting date
12 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jul 2017
Reporting date
13 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SC 13G/A

Filing date
07 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89140

SCHEDULE 13G

Filing date
30 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
29 Jun 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
28 Jun 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jun 2017
Reporting date
26 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .